Live: Will Oracle Crush Q4 Earnings After the Market Closes Tonight?

Health and Healthcare

Health and Healthcare Articles

All Health and Healthcare Articles

5865 Articles

Chris Lange | Aug 31, 2020 at 11:01 AM EDT

What Akcea Shareholders Get in the Ionis Buyout

Akcea Therapeutics stock jumped on Monday after it was announced that Ionis Pharmaceuticals would be acquiring all of its outstanding…

Lee Jackson | Aug 27, 2020 at 8:50 AM EDT

Why Dividend-Paying Big Drug Companies May Be the Best Stocks to Own Now

These five dividend-paying large-cap pharmaceutical stocks look like outstanding ideas for nervous investors looking for income and a degree of…

Chris Lange | Aug 26, 2020 at 11:30 AM EDT

Why Fluidigm’s COVID-19 Saliva-Based Test Is a Huge Hit

Fluidigm made a splash with the markets on Wednesday morning after the company announced a critical update from the FDA…

Jon C. Ogg | Aug 26, 2020 at 11:21 AM EDT

Analyst Sees Moderna as Cheap Ahead of Interim COVID-19 Data

Independent research firm Argus has reiterated its Buy rating on Moderna and is calling this large pullback a buying opportunity.

Chris Lange | Aug 26, 2020 at 10:13 AM EDT

Major Biotechs Scare Off Short Sellers

The August 14 short interest data has been compared with the previous report, and short interest in most of these…

Chris Lange | Aug 25, 2020 at 11:38 AM EDT

How Medtronic Crushed Its Q1

Medtronic reported better than expected quarterly results before the markets opened on Tuesday.

Paul Ausick | Aug 25, 2020 at 8:34 AM EDT

Don’t Have a Heart Attack During the Pandemic

Has the COVID-19 pandemic discouraged bystanders from helping a person who may be suffering from a heart attack?

Chris Lange | Aug 24, 2020 at 12:21 PM EDT

This Cancer Genetics Merger Could Be the Future for Biotechs

Cancer Genetics shares more than doubled on Monday after the company announced a merger with StemoniX.

Chris Lange | Aug 24, 2020 at 11:56 AM EDT

Is Onconova Therapeutics in Serious Trouble After This Late-Stage Cancer Study?

Onconova Therapeutics stock was absolutely crushed to start out the week after the company reported results from its late-stage cancer…

Douglas A. McIntyre | Aug 22, 2020 at 8:19 AM EDT

India Has 3 Million COVID-19 Cases, and the Number Is Likely Millions More

What are India's real confirmed case and death numbers? No one will ever know. A low testing rate and poor…

Chris Lange | Aug 21, 2020 at 9:35 AM EDT

The Data Just Keeps Getting Better for Pfizer and BioNTech’s COVID-19 Vaccine

Pfizer and BioNTech provided an update for their coronavirus vaccine that is currently in the late stages of development and…

Chris Lange | Aug 19, 2020 at 11:33 AM EDT

Johnson & Johnson’s Newest Multibillion Dollar Acquisition

After Momenta Pharmaceuticals announced that it would be acquired by pharmaceutical giant Johnson & Johnson, the biotechnology company's shares soared…

Chris Lange | Aug 19, 2020 at 10:25 AM EDT

The FDA Comes Down on Gilead and Galapagos With CRL

The FDA has come down on an investigational treatment for moderately to severely active from Gilead Sciences and Galapagos.

Chris Lange | Aug 19, 2020 at 9:55 AM EDT

What This FDA Response Means for BioMarin’s Gene Therapy for Hemophilia

BioMarin Pharmaceutical stock was crushed on Wednesday after an FDA response regarding its valoctocogene roxaparvovec gene therapy for severe hemophilia…

Chris Lange | Aug 18, 2020 at 10:40 AM EDT

Vanda Pharma’s Big Step Forward in COVID-19 Pneumonia

Vanda Pharmaceuticals took another big step forward in the fight against COVID-19 on Tuesday morning.

1 … 43 44 45 46 47 … 392

Health and Healthcare Articles

All Health and Healthcare Articles

What Akcea Shareholders Get in the Ionis Buyout

Why Dividend-Paying Big Drug Companies May Be the Best Stocks to Own Now

Why Fluidigm’s COVID-19 Saliva-Based Test Is a Huge Hit

Analyst Sees Moderna as Cheap Ahead of Interim COVID-19 Data

Major Biotechs Scare Off Short Sellers

How Medtronic Crushed Its Q1

Don’t Have a Heart Attack During the Pandemic

This Cancer Genetics Merger Could Be the Future for Biotechs

Is Onconova Therapeutics in Serious Trouble After This Late-Stage Cancer Study?

India Has 3 Million COVID-19 Cases, and the Number Is Likely Millions More

The Data Just Keeps Getting Better for Pfizer and BioNTech’s COVID-19 Vaccine

Johnson & Johnson’s Newest Multibillion Dollar Acquisition

The FDA Comes Down on Gilead and Galapagos With CRL

What This FDA Response Means for BioMarin’s Gene Therapy for Hemophilia

Vanda Pharma’s Big Step Forward in COVID-19 Pneumonia

Live: Will Oracle Crush Q4 Earnings After the Market Closes Tonight?

Wall Street CIO: The AI Trade is “Technically Unsustainable.” Buy These Two Industries Instead.

Wall Street Strategist: SpaceX Will Force a Major Stock Market Repositioning. Buy These Stocks Instead.

3 Dividend Stocks Built for Retirement to Buy in June

Retired Couple With $1.9 Million Faces $4,800 IRMAA Surprise After Stock Sale

A $900,000 Nest Egg at 65 Only Translates to About $36,000 in Real Annual Spending After Taxes and Inflation

Wall Street CIO: The AI Trade is “Technically Unsustainable.” Buy These Two Industries Instead.

Wall Street Strategist: SpaceX Will Force a Major Stock Market Repositioning. Buy These Stocks Instead.

Health and Healthcare Articles

All Health and Healthcare Articles

What Akcea Shareholders Get in the Ionis Buyout

Why Dividend-Paying Big Drug Companies May Be the Best Stocks to Own Now

Why Fluidigm’s COVID-19 Saliva-Based Test Is a Huge Hit

Analyst Sees Moderna as Cheap Ahead of Interim COVID-19 Data

Major Biotechs Scare Off Short Sellers

How Medtronic Crushed Its Q1

Don’t Have a Heart Attack During the Pandemic

This Cancer Genetics Merger Could Be the Future for Biotechs

Is Onconova Therapeutics in Serious Trouble After This Late-Stage Cancer Study?

India Has 3 Million COVID-19 Cases, and the Number Is Likely Millions More

The Data Just Keeps Getting Better for Pfizer and BioNTech’s COVID-19 Vaccine

Johnson & Johnson’s Newest Multibillion Dollar Acquisition

The FDA Comes Down on Gilead and Galapagos With CRL

What This FDA Response Means for BioMarin’s Gene Therapy for Hemophilia

Vanda Pharma’s Big Step Forward in COVID-19 Pneumonia

Live: Will Oracle Crush Q4 Earnings After the Market Closes Tonight?

Wall Street CIO: The AI Trade is “Technically Unsustainable.” Buy These Two Industries Instead.

Wall Street Strategist: SpaceX Will Force a Major Stock Market Repositioning. Buy These Stocks Instead.

3 Dividend Stocks Built for Retirement to Buy in June

Featured Reads

Retired Couple With $1.9 Million Faces $4,800 IRMAA Surprise After Stock Sale

A $900,000 Nest Egg at 65 Only Translates to About $36,000 in Real Annual Spending After Taxes and Inflation